Comparison of Mitochondrial and Antineoplastic Effects of Amiodarone and Desethylamiodarone in MDA-MB-231 Cancer Line
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189781 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Fadi H J Ramadan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary. Hauptthemen laut MEDLINE: Amiodarone, Mitochondria, Antineoplastic Agents, Apoptosis. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry for Innovation and Technology, University of Pecs Medical School, János Bolyai Research Scholarship of the Hungarian Academy of Sciences.
Abstract (Originalsprache)
Previously, we have demonstrated that amiodarone (AM), a widely used antiarrhythmic drug, and its major metabolite desethylamiodarone (DEA) both affect several mitochondrial processes in isolated heart and liver mitochondria. Also, we have established DEA’s antitumor properties in various cancer cell lines and in a rodent metastasis model. In the present study, we compared AM’s and DEA’s mitochondrial and antineoplastic effects in a human triple-negative breast cancer (TNBC) cell line. Both compounds reduced viability in monolayer and sphere cultures and the invasive growth of the MDA-MB-231 TNBC line by inducing apoptosis. They lowered mitochondrial trans-membrane potential, increased Ca2+ influx, induced mitochondrial permeability transition, and promoted mitochondrial fragmentation. In accordance with their mitochondrial effects, both substances massively decreased overall, and even to a greater extent, mitochondrial ATP production decreased, as determined using a Seahorse live cell respirometer. In all these effects, DEA was more effective than AM, indicating that DEA may have higher potential in the therapy of TNBC than its parent compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
- Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary.
ORCID-Profile: Fadi H J Ramadan, Balazs Koszegi, Viola B Vantus, Gyongyi N Kiss, Ferenc Gallyas, Zita Bognar
Förderung
- Ministry for Innovation and Technology
- University of Pecs Medical School
- János Bolyai Research Scholarship of the Hungarian Academy of Sciences
- National Research, Development and Innovation Office, Ministry for Innovation and Technology
Zitieren
APA
Ramadan, F. H. J., Koszegi, B., Vantus, V. B., Fekete, K., Kiss, G. N., Rizsanyi, B., Bognar, R., Gallyas, F., & Bognar, Z. (2024). Comparison of Mitochondrial and Antineoplastic Effects of Amiodarone and Desethylamiodarone in MDA-MB-231 Cancer Line. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189781
Vancouver
Ramadan FHJ, Koszegi B, Vantus VB, Fekete K, Kiss GN, Rizsanyi B, et al. Comparison of Mitochondrial and Antineoplastic Effects of Amiodarone and Desethylamiodarone in MDA-MB-231 Cancer Line. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189781
BibTeX
@article{Ramadan2024,
author = {Ramadan, Fadi H J and Koszegi, Balazs and Vantus, Viola B and Fekete, Katalin and Kiss, Gyongyi N and Rizsanyi, Balint and Bognar, Rita and Gallyas, Ferenc and Bognar, Zita},
title = {Comparison of Mitochondrial and Antineoplastic Effects of Amiodarone and Desethylamiodarone in MDA-MB-231 Cancer Line},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189781}
}
EUVIMED